logo

VNRX

Volitionrx·AMEX
--
--(--)
--
--(--)
1.10 / 10
Underperform

Financial evaluation reveals challenging fundamentals for VNRX, scoring only 1.1/10. Key issues include negative asset-to-market value (-0.5007) and revenue-to-market value (-3.1006) differences, both in the first performance group, historically associated with negative monthly returns. Net income-to-revenue is also negative (-0.1668), and both ROA (-217.0627) and annualized net profit margin are highly negative, confirming weak profitability. Cash metrics (Cash-MV: -0.0673, Cash-UP: -0.0574) are subpar, though interest coverage ratio (15.4844) is adequate. Overall, the financial underpinnings are fragile, limiting upside potential.

Fundamental(1.1)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value-3.10
Score2/3
Weight-0.29%
1M Return0.09%
ROA (%)
Value-217.06
Score0/3
Weight16.56%
1M Return-7.78%
Net profit attributable to parent company shareholders / Net profit (%)
Value99.34
Score2/3
Weight5.56%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight7.85%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight13.56%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-289.42
Score0/3
Weight16.56%
1M Return-7.78%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight6.27%
1M Return-1.95%
Asset-MV
Value-0.50
Score0/3
Weight10.51%
1M Return-3.57%
Cash-MV
Value-0.07
Score1/3
Weight14.90%
1M Return-5.64%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight8.51%
1M Return-2.89%
Is VNRX undervalued or overvalued?
  • VNRX scores 1.10/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -1566.41% net margin, -1.30 P/E ratio, -0.84 P/B ratio, and 36.11% earnings growth, these metrics solidify its Underperform investment rating.